Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The growth hormone-releasing factor receptor (GHRHR) is a G-protein-coupled receptor primarily expressed in the anterior pituitary gland. It binds growth hormone-releasing hormone (GHRH) to stimulate the synthesis and release of growth hormone (GH). This process regulates body size, metabolism, and proliferation/differentiation of somatotroph cells. Mutations are associated with isolated growth-hormone deficiency. It signals through cAMP-dependent and Phospholipase C pathways.
Binding of GHRH activates Gs protein, leading to increased cAMP and PKA activation, ultimately increasing GH gene transcription and release. Activation via βγ-complex leads to PLC activation, DAG & IP3 production, IP3 increases intracellular Ca²⁺ causing vesicle fusion & GH secretion. Opens Na⁺ channels via phosphatidylinositol 4,5-bisphosphate; depolarization opens voltage-dependent Ca²⁺ channels for further GH release.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth hormone-releasing factor receptor (GHRHR).